drugset / Trial / NCT00140049

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

NCT00140049

Phase 4 Completed 238 enrolled Viatris Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

To demonstrate the statistical non inferiority of the combination of latanoprost and timolol given in the evening time once a day vs the combination of dorzamalide and timolol twice a day based on intraocular pressure measurements at 8 AM, 12 noon \& 4 PM during a 12 week treatment.

Timeline

Start
2005-07
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dorzolamide Small molecule
Subject Latanoprost Small molecule
Background Timolol Other / unclassified